GH Research PLC
GHRSNASDAQHealthcare● Active
$20.12
$-1.31(-6.11%)
Market Cap$1.4B
P/E Ratio—
52W High$25.94
52W Low$11.32
GH Research PLC (GHRS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GHRS · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
-$0.31
Est. -$0.27 · -14.8%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▼ Miss EPS
GHRS reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$0.31 | — | — | — | — | — |
| ▼ Q2 FY2026 | May 14, 2026 | -$0.27 | -$0.31 | -14.8% | — | — | — |
| ▲ Q1 FY2026 | Mar 5, 2026 | -$0.29 | -$0.23 | +20.7% | — | — | — |
| — Q4 FY2025 | Nov 6, 2025 | -$0.23 | -$0.23 | +0.0% | — | — | — |
| ▲ Q3 FY2025 | Aug 7, 2025 | -$0.22 | -$0.15 | +31.8% | — | — | — |
| ▲ Q2 FY2025 | May 8, 2025 | -$0.61 | -$0.19 | +68.8% | — | — | — |
| ▲ Q1 FY2025 | Feb 27, 2025 | -$0.23 | -$0.17 | +26.1% | — | — | — |
| ▲ Q4 FY2024 | Nov 14, 2024 | -$0.25 | -$0.23 | +8.0% | — | — | — |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$0.31
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Miss
EPS Actual
-$0.31
EPS Est.
-$0.27
EPS Surpr.
-14.8%
Revenue
—
Q1 FY2026
Mar 5, 2026Beat
EPS Actual
-$0.23
EPS Est.
-$0.29
EPS Surpr.
+20.7%
Revenue
—
Q4 FY2025
Nov 6, 2025
EPS Actual
-$0.23
EPS Est.
-$0.23
EPS Surpr.
+0.0%
Revenue
—
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
-$0.15
EPS Est.
-$0.22
EPS Surpr.
+31.8%
Revenue
—
Q2 FY2025
May 8, 2025Beat
EPS Actual
-$0.19
EPS Est.
-$0.61
EPS Surpr.
+68.8%
Revenue
—
Q1 FY2025
Feb 27, 2025Beat
EPS Actual
-$0.17
EPS Est.
-$0.23
EPS Surpr.
+26.1%
Revenue
—
Q4 FY2024
Nov 14, 2024Beat
EPS Actual
-$0.23
EPS Est.
-$0.25
EPS Surpr.
+8.0%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.47 | $-0.47 | $-0.47 | 1 |
| Q3 FY2027 | $-0.43 | $-0.43 | $-0.43 | 1 |
| Q2 FY2027 | $-0.39 | $-0.39 | $-0.39 | 1 |
| Q1 FY2027 | $-0.35 | $-0.35 | $-0.35 | 1 |
| Q4 FY2026 | $-0.43 | $-0.43 | $-0.43 | 1 |
| Q3 FY2026 | $-0.43 | $-0.37 | $-0.31 | 5 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 14, 2026 | -14.8% | $21.88 | $22.21 | +1.51% |
| ▲ Q1 FY2026 | Mar 5, 2026 | +20.7% | $15.99 | $15.17 | -5.13% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +0.0% | $13.59 | $13.41 | -1.32% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +31.8% | $12.15 | $12.10 | -0.41% |
| ▲ Q2 FY2025 | May 8, 2025 | +68.8% | $10.27 | $10.80 | +5.16% |
| ▲ Q1 FY2025 | Feb 27, 2025 | +26.1% | $10.97 | $10.65 | -2.92% |
| ▲ Q4 FY2024 | Nov 14, 2024 | +8.0% | $9.24 | $8.97 | -2.92% |
| ▲ Q3 FY2024 | Sep 3, 2024 | +13.0% | No price data | $9.81 | — |
Q2 FY2026+1.51%
Report Date
May 14, 2026
EPS Beat/Miss
-14.8%
Price Before
$21.88
Price After
$22.21
Q1 FY2026-5.13%
Report Date
Mar 5, 2026
EPS Beat/Miss
+20.7%
Price Before
$15.99
Price After
$15.17
Q4 FY2025-1.32%
Report Date
Nov 6, 2025
EPS Beat/Miss
+0.0%
Price Before
$13.59
Price After
$13.41
Q3 FY2025-0.41%
Report Date
Aug 7, 2025
EPS Beat/Miss
+31.8%
Price Before
$12.15
Price After
$12.10
Q2 FY2025+5.16%
Report Date
May 8, 2025
EPS Beat/Miss
+68.8%
Price Before
$10.27
Price After
$10.80
Q1 FY2025-2.92%
Report Date
Feb 27, 2025
EPS Beat/Miss
+26.1%
Price Before
$10.97
Price After
$10.65
Q4 FY2024-2.92%
Report Date
Nov 14, 2024
EPS Beat/Miss
+8.0%
Price Before
$9.24
Price After
$8.97
Q3 FY2024—
Report Date
Sep 3, 2024
EPS Beat/Miss
+13.0%
Price Before
—
Price After
$9.81
Avg Beat Reaction-1.26%
Avg Miss Reaction+1.51%
Beat Rate7 / 8 quarters
Largest Move+5.16% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GHRS ends December
GH Research PLC (GHRS) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-0.31 — missing the analyst consensus of $-0.27 by -14.8%. The next GHRS earnings date is expected around September 1, 2026.
Each quarter, investors track GHRS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GHRS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GHRS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GHRS earnings · 5 questionsGH Research PLC's next earnings report is expected around September 1, 2026. GHRS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GHRS historically reports after market close (AMC).
GHRS earnings datewhen is GHRS earningsGHRS next earnings datewhen does GHRS report earningsGHRS earnings calendar
▸ Source: FMP · GH Research PLC SEC filings · US GAAP · GH Research PLC SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026